Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Drug Nomenclature01:17

Drug Nomenclature

During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that the same...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Drug Concentrations: Measurements01:23

Drug Concentrations: Measurements

Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma —...
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Network-driven discovery of repurposable drugs targeting hallmarks of aging.

Nature aging·2026
Same author

The aging genome exhibits organized vulnerability to somatic mutations.

bioRxiv : the preprint server for biology·2026
Same author

Hungary's chance to rebuild science.

Science (New York, N.Y.)·2026
Same author

Human mobility in the metaverse mirrors patterns in the physical world.

Scientific reports·2026
Same author

Large language models in food and nutrition science: Opportunities, challenges, and the case of FoodyLLM.

Current research in food science·2026
Same author

Revealing interactions between microbes, metabolites, and dietary compounds using genome-scale analysis.

Microbiome·2026
Same journal

conMItion: an R package adjusting confounding factors for associations in multi-omics.

Bioinformatics (Oxford, England)·2026
Same journal

SpaMFG: a Spatial Multi-omics Integration Method based on Feature Grouping.

Bioinformatics (Oxford, England)·2026
Same journal

CSCN: Inference of Cell-Specific Causal Networks Using Single-Cell RNA-Seq Data.

Bioinformatics (Oxford, England)·2026
Same journal

Sparse CCA-Based Mediation Analysis with High-Dimensional Exposures and Mediators.

Bioinformatics (Oxford, England)·2026
Same journal

Enhancing Cross-Context Generalization in Drug Perturbation Prediction with a Multimodal Conditional Diffusion Framework.

Bioinformatics (Oxford, England)·2026
Same journal

Primer Design through Submodular Function Estimation.

Bioinformatics (Oxford, England)·2026
See all related articles

Related Experiment Video

Updated: Jun 19, 2026

Large-Scale Screens of Metagenomic Libraries
16:05

Large-Scale Screens of Metagenomic Libraries

Published on: May 28, 2007

8.8K

NetMedPy: a Python package for large-scale network medicine screening.

Andrés Aldana1, Rodrigo Dorantes-Gilardi1, Michael Sebek2

  • 1Network Science Institute, Northeastern University, 177 Huntington Avenue, Boston, MA 02115, USA.

Bioinformatics (Oxford, England)
|June 27, 2025
PubMed
Summary
This summary is machine-generated.

We developed NetMedPy, an efficient Python package for network medicine. It addresses limitations in current tools, enabling better analysis of sub-cellular networks for disease research and drug discovery.

More Related Videos

Mass Spectrometry-Guided Genome Mining as a Tool to Uncover Novel Natural Products
11:13

Mass Spectrometry-Guided Genome Mining as a Tool to Uncover Novel Natural Products

Published on: March 12, 2020

11.1K
Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

2.7K

Related Experiment Videos

Last Updated: Jun 19, 2026

Large-Scale Screens of Metagenomic Libraries
16:05

Large-Scale Screens of Metagenomic Libraries

Published on: May 28, 2007

8.8K
Mass Spectrometry-Guided Genome Mining as a Tool to Uncover Novel Natural Products
11:13

Mass Spectrometry-Guided Genome Mining as a Tool to Uncover Novel Natural Products

Published on: March 12, 2020

11.1K
Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

2.7K

Area of Science:

  • Computational Biology
  • Bioinformatics
  • Systems Biology

Background:

  • Network medicine analyzes information flow in sub-cellular networks to understand disease and guide drug discovery.
  • Existing network medicine tools lack efficient data processing for complex analyses like large-scale screening and modeling.

Purpose of the Study:

  • To introduce NetMedPy, a versatile and computationally efficient Python package.
  • To overcome limitations in current network medicine toolsets for data processing and analysis.

Main Methods:

  • NetMedPy is an open-source Python package.
  • It supports diverse scoring functions, network distance metrics, and null models.
  • The package is designed for efficient data processing and can run on standard computers or clusters.

Main Results:

  • NetMedPy provides a computationally efficient solution for network medicine analyses.
  • It enhances the application of network medicine in large-scale molecular screening, hypothesis testing, and ensemble modeling.
  • The package facilitates the elucidation of disease etiology, comorbidity, drug efficacy prediction, and therapeutic target identification.

Conclusions:

  • NetMedPy offers a powerful and accessible tool for advancing network medicine research.
  • Its efficiency and versatility support comprehensive analyses of molecular networks.
  • The package is poised to accelerate discoveries in disease mechanisms and therapeutic strategies.